UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

AMP-activated protein kinase and metabolic control

Handbook of experimental pharmacology, 2011-01 (203), p.303

2011

Volltextzugriff (PDF)

Potassium channel openers require ATP to bind to and act through sulfonylurea receptors

The EMBO journal, 1998-10, Vol.17 (19), p.5529-5535

1998

Volltextzugriff (PDF)

Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes

Handbook of experimental pharmacology, 2011 (203), p.75

2011

Volltextzugriff (PDF)

Synthesis and evaluation of a glibenclamide glucose-conjugate: A potential new lead compound for substituted glibenclamide derivatives as islet imaging agents

Regulatory peptides, 2007-03, Vol.139 (1), p.122-127

2007

Volltextzugriff (PDF)

In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans

Experimental and clinical endocrinology & diabetes, 2005-07, Vol.113 (7), p.388

2005

Volltextzugriff (PDF)

Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes

Handbook of experimental pharmacology, 2011 (203), p.279

2011

Volltextzugriff (PDF)

Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects

Handbook of experimental pharmacology, 2011 (203), p.357

2011

Volltextzugriff (PDF)

Sulfonylurea receptors and mechanism of sulfonylurea action

Experimental and clinical endocrinology & diabetes, 1996, Vol.104 (1), p.1

1996

Volltextzugriff (PDF)

Synthesis and evaluation of (S)-2-(2-[ 18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([ 18F]repaglinide): a promising radioligand for quantification of pancreatic β-cell mass with positron emission tomography (PET)

Nuclear medicine and biology, 2004-07, Vol.31 (5), p.639-647

2004

Volltextzugriff (PDF)

Dual acting and pan-PPAR activators as potential anti-diabetic therapies

Handbook of experimental pharmacology, 2011 (203), p.35

2011

Volltextzugriff (PDF)

Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes

Handbook of experimental pharmacology, 2011 (203), p.257

2011

Volltextzugriff (PDF)

GLP-1 agonists and dipeptidyl-peptidase IV inhibitors

Handbook of experimental pharmacology, 2011 (203), p.53

Gallwitz, Baptist

2011

Volltextzugriff (PDF)

Nampt and its potential role in inflammation and type 2 diabetes

Handbook of experimental pharmacology, 2011 (203), p.147

2011

Volltextzugriff (PDF)

SGLT inhibitors as new therapeutic tools in the treatment of diabetes

Handbook of experimental pharmacology, 2011 (203), p.105

2011

Volltextzugriff (PDF)

Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy

Handbook of experimental pharmacology, 2011 (203), p.127

Wang, Minghan

2011

Volltextzugriff (PDF)

Nucleotide Sensitivity of Pancreatic ATP-Sensitive Potassium Channels and Type 2 Diabetes

Diabetes (New York, N.Y.), 2002-12, Vol.51 (suppl 3), p.S358-S362

2002

Volltextzugriff (PDF)

Mitochondria as potential targets in antidiabetic therapy

Handbook of experimental pharmacology, 2011 (203), p.331

2011

Volltextzugriff (PDF)

Overcoming insulin resistance with ciliary neurotrophic factor

Handbook of experimental pharmacology, 2011 (203), p.179

2011

Volltextzugriff (PDF)

Thermogenesis and related metabolic targets in anti-diabetic therapy

Handbook of experimental pharmacology, 2011 (203), p.201

Arch, Jonathan R S

2011

Volltextzugriff (PDF)

Targeting type 2 diabetes

Handbook of experimental pharmacology, 2011 (203), p.1

2011

Volltextzugriff (PDF)

Identification of the Potassium Channel Opener Site on Sulfonylurea Receptors

The Journal of biological chemistry, 1999-10, Vol.274 (40), p.28079-28082

1999

Volltextzugriff (PDF)

ATP4- mediates closure of pancreatic beta-cell ATP-sensitive potassium channels by interaction with 1 of 4 identical sites

Diabetes (New York, N.Y.), 2000-09, Vol.49 (9), p.1413-1418

2000

Volltextzugriff (PDF)

Inhibition of ganglioside biosynthesis as a novel therapeutic approach in insulin resistance

Handbook of experimental pharmacology, 2011 (203), p.165

Inokuchi, Jin-Ichi

2011

Volltextzugriff (PDF)

Potassium channel openers require ATP to bind to and act through sulfonylurea receptors

The EMBO journal, 1998-10, Vol.17 (19), p.5529-5535

1998

Volltextzugriff (PDF)

Association and stoichiometry of K(ATP) channel subunits

Neuron (Cambridge, Mass.), 1997-05, Vol.18 (5), p.827

1997

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(39)
Buchkapitel
(14)

Sprache

Englisch
(53)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(39)
Science & Technology
(39)
Animals
(38)
Pharmacology & Pharmacy
(26)
Humans
(24)
Sulfonylurea Receptors
(20)
Potassium Channels, Inwardly Rectifying
(18)
Biological And Medical Sciences
(17)
Diabetes
(17)
Atp-Binding Cassette Transporters
(16)
Islets Of Langerhans - Metabolism
(16)
Pharmacology
(14)
Receptors, Drug - Metabolism
(14)
Potassium Channels - Metabolism
(13)
Hypoglycemic Agents - Pharmacology
(12)
Insulin - Metabolism
(12)
Insulin Secretion
(11)
Medical Sciences
(11)
Mice
(11)
Hypoglycemic Agents - Therapeutic Use
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

AMP-activated protein kinase and metabolic control

Potassium channel openers require ATP to bind to and act through sulfonylurea receptors

Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes

Synthesis and evaluation of a glibenclamide glucose-conjugate: A potential new lead compound for substituted glibenclamide derivatives as islet imaging agents

In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans

Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes

Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects

Sulfonylurea receptors and mechanism of sulfonylurea action

Synthesis and evaluation of (S)-2-(2-[ 18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([ 18F]repaglinide): a promising radioligand for quantification of pancreatic β-cell mass with positron emission tomography (PET)

Dual acting and pan-PPAR activators as potential anti-diabetic therapies

Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes

GLP-1 agonists and dipeptidyl-peptidase IV inhibitors

Nampt and its potential role in inflammation and type 2 diabetes

SGLT inhibitors as new therapeutic tools in the treatment of diabetes

Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy

Nucleotide Sensitivity of Pancreatic ATP-Sensitive Potassium Channels and Type 2 Diabetes

Mitochondria as potential targets in antidiabetic therapy

Overcoming insulin resistance with ciliary neurotrophic factor

Thermogenesis and related metabolic targets in anti-diabetic therapy

Targeting type 2 diabetes

Identification of the Potassium Channel Opener Site on Sulfonylurea Receptors

ATP4- mediates closure of pancreatic beta-cell ATP-sensitive potassium channels by interaction with 1 of 4 identical sites

Inhibition of ganglioside biosynthesis as a novel therapeutic approach in insulin resistance

Potassium channel openers require ATP to bind to and act through sulfonylurea receptors

Association and stoichiometry of K(ATP) channel subunits

Suchergebnisse filtern